ATAI Life Sciences N.V. (ATAI) Financials

ATAI Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 308.2 million 39.7 million
2023-06-30 253.6 million 38.0 million
2023-03-31 280.7 million 276.9 million
2022-12-31 305.4 million 300.4 million

ATAI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -18.4 million 8.3 million
2023-06-30 -22.7 million 8.8 million
2023-03-31 -21.6 million 8.7 million
2022-12-31 -30.7 million 12.1 million

ATAI Net Income

No data available :(

ATAI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 209.0 million - 1.3 million
2023-06-30 227.5 million 14.9 million 1.4 million
2023-03-31 249.9 million 14.8 million 1.5 million
2022-12-31 273.1 million 14.7 million -

ATAI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 177.6 million
2023-06-30 155.8 million
2023-03-31 155.8 million
2022-12-31 158.7 million

ATAI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 2000 13.3 million 13.6 million -
2023-06-30 128000 15.5 million 16.6 million -
2023-03-31 443000 19.3 million 14.0 million -
2022-12-31 223000 21.9 million 15.7 million -

ATAI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 87000 74000
2023-06-30 172000 195000
2023-03-31 37000 167000
2022-12-31 38000 53000

ATAI

Price: $2.05

52 week price:
1.03
2.85

Payout Ratio Range:
7.34%
260.00%

Earnings Per Share: -0.43 USD

P/E Ratio: -4.16

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.5 million

Ebitda: 9.8 million

Market Capitalization: 403.4 million

Average Dividend Frequency: 1

Links: